AMNEAL PHARMACEUTICALS, INC. Notes Issued
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Notes Issued of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. notes issued for the quarter ending 2025-12-31 was -$6.00K.
- AMNEAL PHARMACEUTICALS, INC. notes issued for the quarter ending 2025-09-30 was -$20.00K.
- AMNEAL PHARMACEUTICALS, INC. notes issued for the quarter ending 2024-12-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. notes issued for the quarter ending 2024-09-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. notes issued for fiscal 2025 was $476.00K.
- AMNEAL PHARMACEUTICALS, INC. notes issued for fiscal 2024 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. notes issued for fiscal 2023 was $0.00.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$26.00K derived: sum of 2 quarters · filed 2026-02-27 | $476.00K 10-K · filed 2026-02-27 | |
| 2025-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $482.00K 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | $502.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |